Literature DB >> 33622377

A comprehensive review of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease.

Arezoo Gowhari Shabgah1, Fatemeh Norouzi2, Mahdiyeh Hedayati-Moghadam3, Davood Soleimani4, Naseh Pahlavani5, Jamshid Gholizadeh Navashenaq6.   

Abstract

One of the most prevalent diseases worldwide without a fully-known mechanism is non-alcoholic fatty liver disease (NAFLD). Recently, long non-coding RNAs (lncRNAs) have emerged as significant regulatory molecules. These RNAs have been claimed by bioinformatic research that is involved in biologic processes, including cell cycle, transcription factor regulation, fatty acids metabolism, and-so-forth. There is a body of evidence that lncRNAs have a pivotal role in triglyceride, cholesterol, and lipoprotein metabolism. Moreover, lncRNAs by up- or down-regulation of the downstream molecules in fatty acid metabolism may determine the fatty acid deposition in the liver. Therefore, lncRNAs have attracted considerable interest in NAFLD pathology and research. In this review, we provide all of the lncRNAs and their possible mechanisms which have been introduced up to now. It is hoped that this study would provide deep insight into the role of lncRNAs in NAFLD to recognize the better molecular targets for therapy.

Entities:  

Keywords:  Fatty liver; LncRNA; NAFLD; NASH; Non-coding RNA

Year:  2021        PMID: 33622377      PMCID: PMC7903707          DOI: 10.1186/s12986-021-00552-5

Source DB:  PubMed          Journal:  Nutr Metab (Lond)        ISSN: 1743-7075            Impact factor:   4.169


  139 in total

1.  USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation.

Authors:  Zhenghong Lin; Heeyoung Yang; Can Tan; Jinping Li; Zhaojian Liu; Qiu Quan; Sinyi Kong; Junsheng Ye; Beixue Gao; Deyu Fang
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

2.  Glycogen synthase kinase (GSK)-3 and mammalian target of rapamycin complex 1 (mTORC1) cooperate to regulate protein S6 kinase 1 (S6K1).

Authors:  Sejeong Shin; Laura Wolgamott; Sang-Oh Yoon
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

3.  Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2.

Authors:  Niroshika Keppetipola; Shalini Sharma; Qin Li; Douglas L Black
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-06-02       Impact factor: 8.250

4.  Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.

Authors:  Qiong Wang; Lei Jiang; Jue Wang; Shoufeng Li; Yue Yu; Jia You; Rong Zeng; Xiang Gao; Liangyou Rui; Wenjun Li; Yong Liu
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

5.  Runt-related Transcription Factor 1 (RUNX1) Binds to p50 in Macrophages and Enhances TLR4-triggered Inflammation and Septic Shock.

Authors:  Mao-Cai Luo; Si-Yuan Zhou; Dan-Ying Feng; Jun Xiao; Wei-Yun Li; Chun-Di Xu; Hong-Yan Wang; Tong Zhou
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

6.  An RNA-binding domain in the thyroid hormone receptor enhances transcriptional activation.

Authors:  Bin Xu; Ronald J Koenig
Journal:  J Biol Chem       Date:  2004-06-04       Impact factor: 5.157

7.  Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.

Authors:  Andreas Teufel; Timo Itzel; Wiebke Erhart; Mario Brosch; Xiao Yu Wang; Yong Ook Kim; Witigo von Schönfels; Alexander Herrmann; Stefan Brückner; Felix Stickel; Jean-François Dufour; Triantafyllos Chavakis; Claus Hellerbrand; Rainer Spang; Thorsten Maass; Thomas Becker; Stefan Schreiber; Clemens Schafmayer; Detlef Schuppan; Jochen Hampe
Journal:  Gastroenterology       Date:  2016-06-16       Impact factor: 22.682

Review 8.  Transcriptional regulation of hepatic lipogenesis.

Authors:  Yuhui Wang; Jose Viscarra; Sun-Joong Kim; Hei Sook Sul
Journal:  Nat Rev Mol Cell Biol       Date:  2015-11       Impact factor: 94.444

9.  The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation.

Authors:  Meng Du; Lin Yuan; Xin Tan; Dandan Huang; Xiaojing Wang; Zhe Zheng; Xiaoxiang Mao; Xiangrao Li; Liu Yang; Kun Huang; Fengxiao Zhang; Yan Wang; Xi Luo; Dan Huang; Kai Huang
Journal:  Nat Commun       Date:  2017-12-11       Impact factor: 14.919

10.  A long non-coding RNA, APOA4-AS, regulates APOA4 expression depending on HuR in mice.

Authors:  Wangshu Qin; Xinzhi Li; Liwei Xie; Sha Li; Jianan Liu; Linna Jia; Xue Dong; Xiaomeng Ren; Junjie Xiao; Changqing Yang; Yifa Zhou; Zheng Chen
Journal:  Nucleic Acids Res       Date:  2016-04-29       Impact factor: 16.971

View more
  10 in total

1.  Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis.

Authors:  Arthur C Sletten; Jessica W Davidson; Busra Yagabasan; Samantha Moores; Michaela Schwaiger-Haber; Hideji Fujiwara; Sarah Gale; Xuntian Jiang; Rohini Sidhu; Susan J Gelman; Shuang Zhao; Gary J Patti; Daniel S Ory; Jean E Schaffer
Journal:  Nat Commun       Date:  2021-09-01       Impact factor: 17.694

2.  Effects of linear periodization of combined training on quality of life of adults with obesity: a blind randomized controlled trial.

Authors:  Willen Remon Tozetto; Larissa Dos Santos Leonel; Tiago Turnes; Giovani Firpo Del Duca
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.379

Review 3.  Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.

Authors:  Eirini Martinou; Marinos Pericleous; Irena Stefanova; Vasha Kaur; Angeliki M Angelidi
Journal:  Diagnostics (Basel)       Date:  2022-02-04

Review 4.  Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma.

Authors:  Nazia Samudh; Creanne Shrilall; Patrick Arbuthnot; Kristie Bloom; Abdullah Ely
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

Review 5.  Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review.

Authors:  Narjes Nasiri-Ansari; Theodoros Androutsakos; Christina-Maria Flessa; Ioannis Kyrou; Gerasimos Siasos; Harpal S Randeva; Eva Kassi; Athanasios G Papavassiliou
Journal:  Cells       Date:  2022-08-12       Impact factor: 7.666

6.  Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death.

Authors:  Reda Albadawy; Amany Helmy Hasanin; Sara H A Agwa; Shaimaa Hamady; Yasmin M Aboul-Ela; Mona Hussien Raafat; Samaa Samir Kamar; Mohamed Othman; Yahia A Yahia; Marwa Matboli
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

Review 7.  Long Non-Coding RNAs: The New Frontier into Understanding the Etiology of Alcohol Use Disorder.

Authors:  Allie N Denham; John Drake; Matthew Gavrilov; Zachary N Taylor; Silviu-Alin Bacanu; Vladimir I Vladimirov
Journal:  Noncoding RNA       Date:  2022-08-04

8.  Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets.

Authors:  Fatemeh Kazeminasab; Maryam Baharlooie; Kamran Ghaedi
Journal:  PPAR Res       Date:  2022-09-17       Impact factor: 4.385

9.  mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease.

Authors:  Marwa Matboli; Shaimaa H Gadallah; Wafaa M Rashed; Amany Helmy Hasanin; Nada Essawy; Hala M Ghanem; Sanaa Eissa
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

Review 10.  Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis.

Authors:  Vicneswarry Dorairaj; Siti Aishah Sulaiman; Nadiah Abu; Nor Azian Abdul Murad
Journal:  Biomedicines       Date:  2021-12-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.